Anhui Bbca Likang Pharmaceutical Co.,Ltd.

On Chemball

My Chemball

As Supplier

My RFQ Manage Products

As Buyer

My RFQ Post RFQ

My Account

+86-571-8627 3270

Anhui BBCA Likang Pharmaceutical Co.,Ltd.

22 YRS

Anhui, China

CNY 138 Million

89910 m²

100-500 people

Main Products: Cefuroxime Axetil

Anhui, China

Contact Supplier

Home Company Profile Contact Us Post Buying Request

ABOUT US

Anhui BBCA Likang Pharmaceutical Co., Ltd. is a modern pharmaceutical enterprise that Anhui Fengyuan Pharmaceutical Co., Ltd. acquired the assets and equipment of the former Bengbu Bayi Pharmaceutical Co., Ltd. and invested in the construction. In 2010, it obtained the right to import and export itself. The company is located in Bengbu high tech Development Zone, with superior geographical location, convenient road traffic and beautiful surrounding environment. The company covers an area of 90000 square meters. The greening rate of the plant reaches 42%. There are 200 employees. The company has an annual production capacity of 8000 tons of paracetamol and 2000 tons of dc90. On August 20, 2011, it obtained the DMF No. (25213) from the FDA of the United States, and on March 30, 2012, it obtained the EU cos Certificate (no.r0-cep2011-278-rev00). The newly launched cefuroxime axetil API project has been put into production with an annual production capacity of 150 tons. The quality of the company's products meets the requirements of Chinese Pharmacopoeia (cp2015 Edition), British Pharmacopoeia (bp2015), European Pharmacopoeia (ep8.0) and American Pharmacopoeia (usp39). It has been well received by customers in the domestic market. In order to meet the requirements of the market, the company is carrying out phase II project construction. After the completion of the second phase project, the company will have an annual production capacity of 20000 tons of paracetamol API and become an important antipyretic and analgesic API production base in China. The construction of an annual output of 3000 tons of natural menthol refining line is under way, and pharmaceutical and daily-use menthol products were officially put into the market in the first half of 2017. The company takes "cherish life, care for health, do a good job in medicine and serve the people" as its mission. While doing a good job in paracetamol API, the company is planning to make use of existing land resources and public facilities, and actively explore the research and development of other APIs, preparations, tablets and health care products projects. We sincerely welcome people with aspirations to cooperate with us and create a better future together!

Basic Information